Canbi  Pharma  Teknoloġiku  Limited
1337918-83-8 ZavegePant

1337918-83-8 ZavegePant

CAS: 1337918-83-8
MF: C36H46N8O3
MW: 638.8
Einecs:
MDL No.:MFCD27938555

Ibgħat l-inkjesta
Deskrizzjoni

Proprjetajiet

Dehra bajda għal solidu abjad
Punt tat-togħlija: 933.7 ± 65. 0 grad
Densità 1.285 ± 0. 06 g / cm3
PKA11.68 ± 0. 70

 

Applikazzjoni:

ZAVEGEPANT huwa affinità għolja tat-tielet ġenerazzjoni u selettività għolja ta 'molekula żgħira ta' antagonist tar-riċettur CGRP. Zavzpr é T (ZavegePant) huwa adattat għal trattament akut ta 'emigranja bi jew mingħajr aura f'adulti.

 

Sinonimi:

ZAVEGEPANT

Vazegepant

1337918-83-8

BMS -742413

Bhv -3500

BMS -742413-01

N - [(2r) -3- (7- methyl -1} h-indazol -5-} yl) -1- [{{{4-} ({1- methylpiperidin -4- yl) Piperazin 11}} yl] -1- oxopropan -2- yl] -4- ({{2-} oxo -1 h-quinolin -3- yl) piperidine {{19} carboxamide

BHV3500

1- PiperidineCarboxamide, 4- (1, 2- dihydro -2-} oxo -3- quinolinyl) -n - ((1r) {-1- (({7- metil -1} H-Indazol {{13 }} yl) metil) -2- (4- (1- metil -4- piperidinyl) -1- piperazinyl) -2- oxoethyl) - -

(R) -n - (3- (7- methyl -1 h-indazol -5-} yl) -1- ({{4-}} ({1- metylpiperidin -4- yl) Piperazin {{1 1}} yl) -1- oxopropan -2- yl) -4- ({{2-} oxo -1, {2-}}} dihydroquinolin {18}} Piperidine {19}}}}}}}}}}}}

BHV 3500

ZevagePant

GTPL11513

BMS742413

BMS 742413

4- (1, 2- dihydro -2- oxo -3- quinolinyl) -n - ((1r) {{{{{{ 8}} ((7- methyl -1 h-indazol -5- yl) methyl) -2- ( 4- (1- methyl -4- piperidinyl) -1- piperazinyl) {-2-} oxoethyl) -1- piperidineCarboxAmideCarboxamide

Zavegepantum

Ex-A6698

 

It-tags Popolari: 1337918-83-8 ZavegePant, iċ-Ċina 1337918-83-8 Manifatturi ZavegePant, fornituri

Inquiry
goTop

(0/10)

clearall